Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication

Table 4

Multivariable analysis: waitlist mortality.

Variable	Waitlist mortality
	value	95% CI	Hazard ratio
Age	0	1.01–1.08	1.04
Indication
Hepatoblastoma	0	2.47–18.84	6.82
Autoimmune cirrhosis	0.20	0.69–5.91	2.02
AHN	0.99	0.35–2.83	1.00
Metabolic disorders	0.30	0.09–2.04	0.44
Other	0	1.76–6.88	3.48
Race and ethnicity
Black	0.37	0.77–1.94	1.23
Life support	0	1.28–4.71	2.45
Insurance
Public	0	1.20–2.65	1.78
Status 1	0	1.77–6.10	3.28
Region
AR, LA, MS, AL, GA, FL	0.15	0.85–2.75	1.53
Initial laboratory values
INR	0.06	0.99–1.16	1.07
Albumin	0.14	0.62–1.06	0.81